Rare diseases
Investigational molecules
Locations
Back to Sweden745 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study of Acalabrutinib and Rituximab for Elderly Patients with Untreated Mantle Cell Lymphoma
SwedenStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
SwedenStudy on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies
SwedenStudy Comparing Rituximab with Ibrutinib to Rituximab with Chemotherapy for Older Patients with Untreated Mantle Cell Lymphoma
SwedenStudy Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
SwedenStudy on the Safety and Tolerability of OsteoDex for Patients with Relapsed or Refractory Multiple Myeloma
SwedenStudy on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant
SwedenStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
SwedenStudy on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)
SwedenStudy of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)
SwedenStudy on INZ-701 for Improving Survival in Infants with ENPP1 Deficiency
SwedenStudy on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
SwedenThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.
Innovative research comparing various treatment protocols and investigating survival outcomes.
Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.
Focus on prevention and immune response in various age groups.
Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.
Emphasis on improving patient outcomes and testing novel drug combinations.
Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.
Studies evaluating both novel and existing therapeutic approaches.
Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.
Focus on lifestyle interventions combined with pharmaceutical approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
